REFERENCES
1. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101-24.
2. Mendes BB, Conniot J, Avital A, et al. Nanodelivery of nucleic acids. Nat Rev Methods Primers. 2022;2:24.
3. Cheng H, Liao J, Ma Y, Sarwar MT, Yang H. Advances in targeted therapy for tumor with nanocarriers: A review. Mater Today Bio. 2025;31:101583.
4. Tenchov R, Hughes KJ, Ganesan M, et al. Transforming medicine: cutting-edge applications of nanoscale materials in drug delivery. ACS Nano. 2025;19:4011-38.
5. Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6:1078-94.
6. Oh JY, Villaseñor KE, Kian AC, Cormode DP. Advances in ultrasmall inorganic nanoparticles for nanomedicine: from diagnosis to therapeutics. ACS Appl Mater Interfaces. 2025;17:28982-9001.
7. Vallet-Regí M, Schüth F, Lozano D, Colilla M, Manzano M. Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? Chem Soc Rev 2022;51:5365-451.
8. Manzano M, Vallet-Regí M. Mesoporous silica nanoparticles in biomedicine: advances and prospects. Adv Mater. 2025;:e12433.
9. Bittner B, Sánchez-Félix M, Lee D, et al. Drug delivery breakthrough technologies - a perspective on clinical and societal impact. J Control Release. 2023;360:335-43.
10. Hashida M. Advocation and advancements of EPR effect theory in drug delivery science: A commentary. J Control Release. 2022;346:355-7.
11. Dasgupta A, Sofias AM, Kiessling F, Lammers T. Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact. Nat Rev Bioeng. 2024;2:714-6.
12. Fang RH, Zhang L. Nanoparticle-based modulation of the immune system. Annu Rev Chem Biomol Eng. 2016;7:305-26.
13. Zhang T, Tai Z, Cui Z, Chai R, Zhu Q, Chen Z. Nano-engineered immune cells as “guided missiles” for cancer therapy. J Control Release. 2022;341:60-79.
14. Liu J, Wang T, Dong J, Lu Y. The blood-brain barriers: novel nanocarriers for central nervous system diseases. J Nanobiotechnology. 2025;23:146.
15. Qian H, Wang J, Dai Z, et al. Pressure-driven microinjection (PMI) of porous-coated balloon for ultrafast endoluminal drug delivery across biological barriers. Sci Adv. 2025;11:eadv1182.
16. Irie T, Das S, Negishi Y. Covalent organic frameworks as precision nanocarriers for targeted drug delivery: developments, hurdles, and horizons. Nanoscale Horiz. 2026;11:928-52.
17. Khalid-Salako F, Salimi Khaligh S, Fathi F, et al. The nanocarrier landscape - evaluating key drug delivery vehicles and their capabilities: a translational perspective. ACS Appl Mater Interfaces. 2025;17:37383-403.
18. Rahoui N, Jiang B, Taloub N, Huang YD. Spatio-temporal control strategy of drug delivery systems based nano structures. J Control Release. 2017;255:176-201.
19. Xu X, Tong X, Shi Y, et al. Spatiotemporally controlled drug release via a click-release system utilizing mono-alkyl-hydroxylamine and cyclooctyne chemistry. Nat Commun. 2026;17:1794.
20. Mahmud MM, Pandey N, Winkles JA, Woodworth GF, Kim AJ. Toward the scale-up production of polymeric nanotherapeutics for cancer clinical trials. Nano Today. 2024;56:102314.
21. Kim KT, Zhu J, Meeuwissen SA, et al. Polymersome stomatocytes: controlled shape transformation in polymer vesicles. J Am Chem Soc. 2010;132:12522-4.
22. Meeuwissen SA, Kim KT, Chen Y, Pochan DJ, van Hest JC. Controlled shape transformation of polymersome stomatocytes. Angew Chem Int Ed Engl. 2011;50:7070-3.
23. Pijpers IAB, Abdelmohsen LKEA, Williams DS, van Hest JCM. Morphology under control: engineering biodegradable stomatocytes. ACS Macro Lett. 2017;6:1217-22.
24. Rikken RS, Engelkamp H, Nolte RJ, et al. Shaping polymersomes into predictable morphologies via out-of-equilibrium self-assembly. Nat Commun. 2016;7:12606.
25. Li W, Zhang S, Sun M, Kleuskens S, Wilson DA. Shape transformation of polymer vesicles. Acc Mater Res. 2024;5:453-66.
26. Shao J, Cao S, Che H, et al. Twin-engine Janus supramolecular nanomotors with counterbalanced motion. J Am Chem Soc. 2022;144:11246-52.
27. Wu H, Sun H, Oerlemans RAJF, et al. Understanding, mimicking, and mitigating radiolytic damage to polymers in liquid phase transmission electron microscopy. adv mater. 2024;36:e2402987.
28. Shao J, Pijpers IAB, Cao S, et al. Biomorphic engineering of multifunctional polylactide stomatocytes toward therapeutic nano-red blood cells. Adv Sci (Weinh). 2019;6:1801678.
29. Wang J, Wu H, Zhu X, et al. Ultrafast light-activated polymeric nanomotors. Nat Commun. 2024;15:4878.
30. Santos SC, Santos JM. An overview of polymersomes and their shape transformation into stomatocytes for use as nanocarriers and nanoreactors. WSEAS Trans Bio Biomed. 2025;22:248-67.
31. Ortiz-Rivera I, Mathesh M, Wilson DA. A supramolecular approach to nanoscale motion: polymersome-based self-propelled nanomotors. Acc Chem Res. 2018;51:1891-900.
32. Shao J, Cao S, Williams DS, Abdelmohsen LKEA, van Hest JCM. Photoactivated polymersome nanomotors: traversing biological barriers. Angew Chem Int Ed Engl. 2020;59:16918-25.
33. Wong CK, Stenzel MH, Thordarson P. Non-spherical polymersomes: formation and characterization. Chem Soc Rev. 2019;48:4019-35.
34. Song S, Han H, Wang J, et al. Polymersome-based nanomotors: preparation, motion control, and biomedical applications. Chem Sci. 2025;16:7106-29.
35. Hossainy S, Kang S, Gómez Medellín JE, et al. Thermoreversibly assembled polymersomes for highly efficient loading, processing and delivery of protein and siRNA biologics. Nat Biomed Eng. 2026;10:427-44.
36. Wang J, Zhan M, Wu H, et al. Bio-propelled stomatocyte nanomotors with glutathione-responsiveness for osteoarthritis treatment. Angew Chem Int Ed Engl. 2026;65:e3640627.
37. Wang J, Polyviou A, Scheerstra JF, et al. Dual-driven biodegradable nanomotors for enhanced cellular uptake. J Mater Chem B. 2025;13:2820-5.
38. van Rhee PG, Rikken RS, Abdelmohsen LK, et al. Polymersome magneto-valves for reversible capture and release of nanoparticles. Nat Commun. 2014;5:5010.
39. Feng C, Jiang X, Shao Q, Pang Q, Jing X, Yan L. Preparation of Permeable Polymersomes for Biomedical Applications. Biomacromolecules. 2026;27:4155-83.
40. Leong J, Teo JY, Aakalu VK, Yang YY, Kong H. Engineering Polymersomes for Diagnostics and Therapy. Adv Healthc Mater. 2018;7:e1701276.
41. Negut I, Bita B. Polymersomes as innovative, stimuli-responsive platforms for cancer therapy. Pharmaceutics. 2024;16:463.
42. Chelliah R, Rubab M, Vijayalakshmi S, Karuvelan M, Barathikannan K, Oh D. Liposomes for drug delivery: classification, therapeutic applications, and limitations. Next Nanotechnology. 2025;8:100209.
43. Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022;27:1372.
44. Ghezzi M, Pescina S, Padula C, et al. Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release. 2021;332:312-36.
45. Figueiras A, Domingues C, Jarak I, et al. New advances in biomedical application of polymeric micelles. Pharmaceutics. 2022;14:1700.
46. Sarode RJ, Mahajan HS. Dendrimers for drug delivery: an overview of its classes, synthesis, and applications. J Drug Deliv Sci Technol. 2024;98:105896.
47. Ni Q, Tomalia DA, Wu J, Galanakou C, Peng L. Precision chemical engineering of dendrimers for nucleic acid delivery. Nat Rev Chem. 2026;10:620-36.
48. Fadaei MR, Fadaei MS, Kheirieh AE, et al. Overview of dendrimers as promising drug delivery systems with insight into anticancer and anti-microbial applications. Int J Pharm X. 2025;10:100390.
49. Beach MA, Nayanathara U, Gao Y, et al. Polymeric nanoparticles for drug delivery. Chem Rev. 2024;124:5505-616.
50. Kumar V, Jha SK, Gupta G, Sahebkar A, Kesharwani P. Unveiling the power of polymeric nanoparticles: Pioneering advances in breast cancer treatment. Adv Colloid Interface Sci. 2025;344:103606.
51. Sreena R, Nathanael AJ. Biodegradable biopolymeric nanoparticles for biomedical applications-challenges and future outlook. Materials (Basel). 2023;16:2364.
52. Abdelmohsen LK, Nijemeisland M, Pawar GM, et al. Dynamic loading and unloading of proteins in polymeric stomatocytes: formation of an enzyme-loaded supramolecular nanomotor. ACS Nano. 2016;10:2652-60.
53. De Martino MT, Tonin F, Yewdall NA, et al. Compartmentalized cross-linked enzymatic nano-aggregates (c-CLEnA) for efficient in-flow biocatalysis. Chem Sci. 2020;11:2765-9.
54. Nijemeisland M, Abdelmohsen LK, Huck WT, Wilson DA, van Hest JC. A compartmentalized out-of-equilibrium enzymatic reaction network for sustained autonomous movement. ACS Cent Sci. 2016;2:843-9.
55. Terracciano R, Liu Y, Varanaraja Z, et al. Poly(2-oxazoline)-based thermoresponsive stomatocytes. Biomacromolecules. 2024;25:6050-9.
56. Peng F, Tu Y, van Hest JC, Wilson DA. Self-guided supramolecular cargo-loaded nanomotors with chemotactic behavior towards cells. Angew Chem Int Ed Engl. 2015;54:11662-5.
57. Pijpers IAB, Cao S, Llopis-Lorente A, et al. Hybrid biodegradable nanomotors through compartmentalized synthesis. Nano Lett. 2020;20:4472-80.
58. Che H, Zhu J, Song S, et al. ATP-mediated transient behavior of stomatocyte nanosystems. Angew Chem Int Ed Engl. 2019;58:13113-8.
59. Tu Y, Peng F, André AA, Men Y, Srinivas M, Wilson DA. Biodegradable hybrid stomatocyte nanomotors for drug delivery. ACS Nano. 2017;11:1957-63.
60. Fusi AD, Li Y, Llopis-Lorente A, Patiño T, van Hest JCM, Abdelmohsen LKEA. Achieving control in micro-/nanomotor mobility. Angew Chem Int Ed Engl. 2023;62:e202214754.
61. Wang J, Liu J, Sümbelli Y, Shao J, Shi X, van Hest JCM. Nanogel-based nitric oxide-driven nanomotor for deep tissue penetration and enhanced tumor therapy. J Control Release. 2024;372:59-68.
62. Guo Y, Wang J, Li G, et al. Oxygen and heat dual-driven stomatocyte nanomotors for highly efficient inflammation-relieved breast tumor photothermal therapy. Adv Funct Mater. 2025;35:2500113.
63. Giaveri S, Abil Z, Kohyama S, et al. Building a synthetic cell together. Nat Commun. 2025;16:7488.
64. Peng H, Zhao M, Liu X, et al. Biomimetic materials to fabricate artificial cells. Chem Rev. 2024;124:13178-215.
65. Tang TD, Huang X. Artificial cells: from basic assembly to directed functionality. Small Methods. 2023;7:e2301446.
66. Schoonen L, van Hest JC. Compartmentalization approaches in soft matter science: from nanoreactor development to organelle mimics. Adv Mater. 2016;28:1109-28.
67. Wang L, Song S, van Hest J, Abdelmohsen LKEA, Huang X, Sánchez S. Biomimicry of cellular motility and communication based on synthetic soft-architectures. Small. 2020;16:e1907680.
68. Mason AF, Yewdall NA, Welzen PLW, et al. Mimicking cellular compartmentalization in a hierarchical protocell through spontaneous spatial organization. ACS Cent Sci. 2019;5:1360-5.
69. Peters RJRW, Louzao I, van Hest JCM. From polymeric nanoreactors to artificial organelles. Chem Sci 2012;3:335-42.
70. Peters RJ, Marguet M, Marais S, Fraaije MW, van Hest JC, Lecommandoux S. Cascade reactions in multicompartmentalized polymersomes. Angew Chem Int Ed Engl. 2014;53:146-50.
71. Han H, Song S, Pu Y, Ivanov T, Cao S. Polymeric artificial cells: from interfacial membranization to cytomimetic architecture engineering. Biomacromolecules. 2026;27:87-111.
72. Maffeis V, Heuberger L, Nikoletić A, Schoenenberger CA, Palivan CG. Synthetic cells revisited: artificial cells construction using polymeric building blocks. Adv Sci (Weinh). 2024;11:e2305837.
73. Deng K, Zhang Y, Jiang W, et al. Metabolism-based artificial organelles: from precise construction to smart theranostics. Mater Today Bio. 2025;35:102573.
74. Zhang P, Wu G, Zhao C, Zhou L, Wang X, Wei S. Magnetic stomatocyte-like nanomotor as photosensitizer carrier for photodynamic therapy based cancer treatment. Colloids Surf B Biointerfaces. 2020;194:111204.
75. Scheerstra J, Wauters A, Tel J, Abdelmohsen L, van Hest J. Polymersomes as a potential platform for cancer immunotherapy. Materials Today Advances. 2022;13:100203.
76. Liu Y, Terracciano R, Scheerstra J, et al. Fast and autonomous mannosylated nanomotors for dynamic cancer cell targeting. Angew Chem Int Ed Engl. 2025;64:e202505717.
77. Liu Y, Le DHT, Yilmaz G, et al. Targeted peptide nanofiber-loaded stomatocytes for combined photodynamic and photothermal therapy. ACS Appl Mater Interfaces. 2025;17:35230-9.
78. Wauters AC, Scheerstra JF, van Leent MMT, et al. Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy. Nat Nanotechnol. 2024;19:1735-44.
79. Sun H, Zhong Z. Bioresponsive polymeric nanoparticles: from design, targeted therapy to cancer immunotherapy. Biomacromolecules. 2025;26:33-42.
80. Porges E, Jenner D, Taylor AW, et al. Antibiotic-loaded polymersomes for clearance of intracellular Burkholderia thailandensis. ACS Nano. 2021;15:19284-97.
81. Wang T, Qin J, Cheng J, Li C, Du J. Intelligent design of polymersomes for antibacterial and anticancer applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022;14:e1822.
82. Landa G, Mendoza G, Irusta S, Arruebo M. Bacteria-responsive nanostructured drug delivery systems for targeted antimicrobial therapy. Adv Mater. 2025;:e10355.
83. Caselli L, Malmsten M. Combining functionalities-nanoarchitectonics for combatting bacterial infection. Adv Colloid Interface Sci. 2025;337:103385.
84. Smerkova K, Dolezelikova K, Bozdechova L, Heger Z, Zurek L, Adam V. Nanomaterials with active targeting as advanced antimicrobials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12:e1636.
85. Flemming HC, van Hullebusch ED, Little BJ, et al. Microbial extracellular polymeric substances in the environment, technology and medicine. Nat Rev Microbiol. 2025;23:87-105.
86. Yang W, Chen M, Li J, et al. Polymer platforms for cardiovascular disease applications. Prog Polym Sci. 2026;180:102154.
87. Patel R, Patel D, Dani U, Kuperkar K. Nanoparticle-driven drug delivery system for cardiovascular treatment. J Cardiol. 2026;87:23-37.
88. Wang Y, Fu J, Zou M, et al. Programming the beating heart with polymer catalysis: a therapeutic microenvironment revolution. J Nanobiotechnol. 2026;24.
89. Lai WF. Design and applications of polymersomes for oral drug administration. ACS Appl Mater Interfaces. 2025;17:30423-35.
90. Matoori S, Leroux J. Twenty-five years of polymersomes: lost in translation? Mater Horiz 2020;7:1297-309.
91. Shen Y, Gwak H, Han B. Advanced manufacturing of nanoparticle formulations of drugs and biologics using microfluidics. Analyst. 2024;149:614-37.
92. Ristroph KD, Pinkerton NM, Markwalter CE, D’Addio SM, Gindy ME, Pagels RF. 20 years of flash nanoprecipitation - from controlled precipitation to global medicine. Adv Drug Deliv Rev. 2025;227:115700.
93. Abeykoon C. Sensing technologies for process monitoring in polymer extrusion: a comprehensive review on past, present and future aspects. Meas: Sens. 2022;22:100381.
94. Wang Z, Wang X, Xu W, et al. Translational challenges and prospective solutions in the implementation of biomimetic delivery systems. Pharmaceutics. 2023;15:2623.
95. Santiago I. Nanoscale active matter matters: challenges and opportunities for self-propelled nanomotors. Nano Today. 2018;19:11-5.
96. Desai N, Rana D, Patel M, Bajwa N, Prasad R, Vora LK. Nanoparticle Therapeutics in clinical perspective: classification, marketed products, and regulatory landscape. Small. 2025;21:e2502315.
97. Shahin MH, Liu Q. Artificial intelligence in clinical and translational science: from bench insights to bedside impact. Clin Transl Sci. 2025;18:e70383.
98. Pourbaghi M, Bradbury MS. Atomic precision in personalized oncology: ai-designed nanomedicines enabling n-of-1 cancer therapy. ACS Nano Med 2026;1:784-90.
99. McDonald SM, Augustine EK, Lanners Q, Rudin C, Catherine Brinson L, Becker ML. Applied machine learning as a driver for polymeric biomaterials design. Nat Commun. 2023;14:4838.
100. Wang Q, Liu Y, Li C, Xu B, Xu S, Liu B. Machine learning-enhanced nanoparticle design for precision cancer drug delivery. Adv Sci (Weinh). 2025;12:e03138.
101. Ge W, De Silva R, Fan Y, Sisson SA, Stenzel MH. Predictive modelling of solvent effects on drug incorporation into polymeric nanocarriers: a machine learning approach. Macromol Rapid Commun. 2026;47:e00251.
102. Azimi S. Intelligent nanoparticle design: unlocking the potential of AI for transformative drug delivery. Curr Opin Biomed Eng. 2025;36:100625.
103. Khalifa M, Albadawy M. AI in diagnostic imaging: revolutionising accuracy and efficiency. Comput Methods Programs Biomed Update. 2024;5:100146.
104. Guo R, Zhang Z, Zhang S, et al. Innovative nanocarriers: synthetic and biomimetic strategies for enhanced drug delivery. Mater Today Bio. 2025;34:102180.
105. Chennamsetty S, Keerikkadu M, Shetty A, Bangera PD, Tippavajhala VK, Rathnanand M. Biohybrid nanocarriers for targeted drug delivery by integrating biological interfaces with synthetic platforms for site-specific therapeutics. Int J Pharm. 2026;687:126400.
106. Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2023;20:33-48.
107. Zhou K, Zhang Z, Wang B, et al. Engineered cell membrane-coated nanoparticles: a new strategy for pancreatic cancer therapy. ACS Pharmacol Transl Sci. 2026;9:1345-64.
108. Su Y, Feng H, Yuan X, et al. Progress of micro/nanomotors for in vivo biomedical applications. Adv Healthc Mater. 2026;15:e03935.
109. Chen S, Fan DE, Fischer P, et al. A roadmap for next-generation nanomotors. Nat Nanotechnol. 2025;20:990-1000.
110. Wen F, Wang L, Li X, et al. Precision nanomedicine for cancer: innovations, strategies, and translational challenges. Onco Targets Ther. 2025;18:1125-48.
111. Baig MS, Ahmad A, Pathan RR, Mishra RK. Precision nanomedicine with bio-inspired nanosystems: recent trends and challenges in mesenchymal stem cells membrane-coated bioengineered nanocarriers in targeted nanotherapeutics. J Xenobiot. 2024;14:827-72.
